Presentation is loading. Please wait.

Presentation is loading. Please wait.

Glucocorticoid Receptor Status Is a Principal Determinant of Variability in the Sensitivity of Non–Small-Cell Lung Cancer Cells to Pemetrexed  Mugdha.

Similar presentations


Presentation on theme: "Glucocorticoid Receptor Status Is a Principal Determinant of Variability in the Sensitivity of Non–Small-Cell Lung Cancer Cells to Pemetrexed  Mugdha."— Presentation transcript:

1 Glucocorticoid Receptor Status Is a Principal Determinant of Variability in the Sensitivity of Non–Small-Cell Lung Cancer Cells to Pemetrexed  Mugdha Patki, MS, Shirish Gadgeel, MD, Yanfang Huang, MS, Thomas McFall, MS, Anthony F. Shields, MD, PhD, Larry H. Matherly, PhD, Gerold Bepler, MD, PhD, Manohar Ratnam, PhD  Journal of Thoracic Oncology  Volume 9, Issue 4, Pages (April 2014) DOI: /JTO Copyright © 2014 International Association for the Study of Lung Cancer Terms and Conditions

2 FIGURE 1 Differential effects of Dex on the expression of genes involved in pemetrexed action in A549 versus H1299 cells. A549 cells (A and C) and H1299 cells (B and D) were plated at 20% confluence in media containing charcoal-stripped serum for 24 hours for hormone depletion. Cells were then treated with either vehicle (ethanol) or Dex (100 nM) for 48 hours. Cells were harvested and total RNA extracted to measure mRNA levels by real-time RT-PCR (A and B). Whole cell lysates were also extracted from the cells to measure the protein levels of TS and DHFR by Western blot; GAPDH was used as the loading control (C and D). *p < All the mRNA measurements were carried out using biological triplicate samples. Dex, dexamethasone; TS, thymidylate synthase; DHFR, dihydrofolate reductase; AICARFT, 5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase; GARFT, glycinamide ribonucleotide formyltransferase; RFC, reduced folate carrier; PCFT, proton coupled folate transporter; FPGS, folyl-polyglutamate synthase; TK1, thymidine kinase 1; RQ, relative quantification. Journal of Thoracic Oncology 2014 9, DOI: ( /JTO ) Copyright © 2014 International Association for the Study of Lung Cancer Terms and Conditions

3 FIGURE 2 Effect of Dex on cell-cycle phase distribution in A549 and H1299 cells. A549 cells (A) and H1299 cells (B) were plated at 20% confluence in media containing charcoal-stripped serum for 24 hours for hormone depletion. Cells were then treated with either vehicle (ethanol) or Dex (100 nM) for 48 hours and harvested for flow cytometry analysis. The experiments were repeated at least three times. Within each experiment, the percent error for replicate samples was < 10%. The p values for Dex induced changes noted in the text were < Dex, dexamethasone. Journal of Thoracic Oncology 2014 9, DOI: ( /JTO ) Copyright © 2014 International Association for the Study of Lung Cancer Terms and Conditions

4 FIGURE 3 Reversibility of Dex effects in A549 cells. A549 cells were plated at 20% confluence in media containing charcoal-stripped serum for 24 hours for hormone depletion. Cells were then treated with either vehicle (ethanol) or Dex (100 nM). After 48 hours, Dex was removed by washing the cells twice and replacing with fresh media. Cells were cultured for additional periods of 24 hours and 48 hours. Cells were harvested for flow cytometry analysis (A). The experiments were repeated at least three times. Within each experiment, the percent error for replicate samples was < 10%. The p values for Dex induced changes noted in the text were < In parallel, cells were harvested for mRNA measurement by real-time reverse transcription polymerase chain reaction (B). *p < All the mRNA measurements were carried out using biological triplicate samples. RQ, relative quantification; Dex, dexamethasone; TS, thymidylate synthase; DHFR, dihydrofolate reductase. Journal of Thoracic Oncology 2014 9, DOI: ( /JTO ) Copyright © 2014 International Association for the Study of Lung Cancer Terms and Conditions

5 FIGURE 4 Effect of restoring GRα on responsiveness to Dex in H1299 cells. H1299-GRα cells were generated as described under Materials and Methods. RNA extracted from A549 cells, H1299 cells, and H1299-GRα cells was used to measure the relative mRNA levels for GRα (A). H1299-GRα cells were plated at 20% confluence in media containing charcoal-stripped serum for 24 hours for hormone depletion. Cells were then treated with either vehicle (ethanol) or Dex (100 nM) for 48 hours. Cells were harvested for mRNA measurement by real-time reverse transcription polymerase chain reaction (B). *p < In parallel, cells were harvested for cell-cycle analysis (C). The experiments were repeated at least three times. Within each experiment, the percent error for replicate samples was < 10 percent. The p values for Dex induced changes noted in the text were < All the mRNA measurements were carried out using biological triplicate samples. GR, glucocorticoid receptor; Dex, dexamethasone; RQ, relative quantification; TS, thymidylate synthase; DHFR, dihydrofolate reductase. Journal of Thoracic Oncology 2014 9, DOI: ( /JTO ) Copyright © 2014 International Association for the Study of Lung Cancer Terms and Conditions

6 FIGURE 5 Effect of knocking down p53 on responsiveness to Dex in H226 cells. The relative p53 expression levels in the parental H226 cells versus H226-p53KD cells were determined by real-time RT-PCR (A). H226-p53KD cells (B) or the parental H226 cells (C) were plated at 20% confluence in media containing charcoal-stripped serum for 24 hours for hormone depletion. Cells were then treated with either vehicle (ethanol) or Dex (100 nM) for 48 hours and then harvested for mRNA measurement by real-time RT-PCR. *p < All the mRNA measurements were carried out using biological triplicate samples. Dex, dexamethasone; RT-PCR, reverse transcription polymerase chain reaction; TS, thymidylate synthase; DHFR, dihydrofolate reductase; TKI, thymidine kinase 1; RQ, relative quantification. Journal of Thoracic Oncology 2014 9, DOI: ( /JTO ) Copyright © 2014 International Association for the Study of Lung Cancer Terms and Conditions

7 FIGURE 6 Differential effects of Dex on growth inhibition by pemetrexed in A549 versus H1299 cells. A549 cells (A) and H1299 cells (B) were plated in six replicate wells in 96-well plates in media containing charcoal-stripped serum as described under Materials and Methods for MTT assays. Twenty-four hours after plating, the cells were treated with vehicle (ethanol) or Dex (100 nM) for 72 to 96 hours. The cells were exposed to pemetrexed (5 μM) or vehicle (water) for a 24-hour window in the midst of the Dex (or vehicle) treatment. MTT assays were performed on the indicated days, beginning with the day of pemetrexed treatment (day 0). At each time point, the ratio of the absorbance for pemetrexed treatment to its vehicle control was used to determine the percentage of viable cells. Dex, dexamethasone; MTT, 3-[4,5-dimethylthiazol-2-yl]-2,5 diphenyl tetrazolium bromide. Journal of Thoracic Oncology 2014 9, DOI: ( /JTO ) Copyright © 2014 International Association for the Study of Lung Cancer Terms and Conditions

8 FIGURE 7 Influence of Dex on inhibition of colony formation by pemetrexed in relation to GRα status. A549 cells (A and D), H1299 cells (B and E), and H1299-GRα cells (C and F) were first plated at 20% confluence in 10-cm dishes in media containing charcoal-stripped serum for hormone depletion. Twenty-four hours later cells were treated with vehicle (ethanol) or Dex (100 nM) for 72 to 96 hours. The cells were exposed to pemetrexed (5 μM) or vehicle (water) for a 24-hour window in the midst of the Dex (or vehicle) treatment. The cells were then plated for the colony-formation assay as described under Materials and Methods. After the colonies were formed, they were stained with crystal violet. The colony counts from replicate wells are represented in form of histograms (D–F). *,**p < Dex, dexamethasone; GR, glucocorticoid receptor. Journal of Thoracic Oncology 2014 9, DOI: ( /JTO ) Copyright © 2014 International Association for the Study of Lung Cancer Terms and Conditions


Download ppt "Glucocorticoid Receptor Status Is a Principal Determinant of Variability in the Sensitivity of Non–Small-Cell Lung Cancer Cells to Pemetrexed  Mugdha."

Similar presentations


Ads by Google